The use of carer assisted adherence therapy for people with Parkinson's disease and their carers (CAAT-PARK): Study protocol for a randomised controlled trial
Daley, D. J., Deane, K. H. O., Gray, R., Worth, P. F., Clark, A. B., Sabanathan, K., Pfeil, M. and Myint, P. K. (2011) The use of carer assisted adherence therapy for people with Parkinson's disease and their carers (CAAT-PARK): Study protocol for a randomised controlled trial. Trials Journal, 12 (251). ISSN 1745-6215
Full text not available from this repository
Publisher's URL: http://dx.doi.org/10.1186/1745-6215-12-251
Pharmacological intervention is essential for managing the symptoms of Parkinson's disease. Adherence to medication regimens however is a major problem. Poor adherence leads to significant motor deterioration and inadequate symptom control. This results in poor quality of life. Whilst interventions to improve medication adherence have shown considerable benefit in other chronic conditions, the efficacy of such treatments in Parkinson's disease is less well researched. Many people with Parkinson's disease require substantial support from spouse/caregivers. This often extends to medication taking. Consequently, spouse/caregiver's support for timely medication management is paramount. We aim to investigate the benefit of a novel intervention, Carer Assisted Adherence Therapy, for improving medication adherence and quality of life in people with Parkinson's disease. Adherence therapy may help to optimise the efficacy of anti-parkinsonian agents, subsequently improving clinical outcomes.